Members of the heat shock protein 70 (HSP70) family display a broad cellula
r localization and thus bind a repertoire of chaperoned peptides potentiall
y derived from proteins of different cellular compartments. In this report,
we show that HSP70 purified from human melanoma can activate T cells recog
nizing melanoma differentiation antigens in an antigen- and HLA class I-dep
endent fashion. HLA class I-restricted antimelanoma T cells were susceptibl
e to MHC-restricted, HSP70-dependent stimulation, indicating that HSP70 com
plexed peptides were able to gain access to the class I HLA presentation pa
thway. In addition, MHC matching between the melanoma cells used as a sourc
e of HSP and the responding T cells were not required, indicating that HSP7
0 activation may occur across MHC barriers. Besides the MHC-restricted and
peptide-dependent activation pathway, HSP70 with no endogenous complexed pe
ptides or HSP70 purified from antigen-negative cells was also able to induc
e IFN-gamma release by antimelanoma T cells by a MHC-independent mechanism.
In this case, however, higher doses of HSP70 were required. The capacity t
o activate class I-restricted, antitumor T cells as well as antigen-present
ing cells, together with the finding that the HSP70 chaperoned peptide repe
rtoire includes melanoma-shared epitopes, holds promise for a HSP70-based c
ancer vaccine.